Studies have shown that active fund managers routinely underperform the S&P500 index*​

Mesoblast Limited (NASDAQ: MESO)

MESO Stock Predictions and Ratings

WSX Rating:
BUY
WSX Forecast (1yr):
16.10%
Analyst Rating:
STRONG BUY
Analyst Forecast (1yr):
NOT AVAILABLE

MESO Stock Analysis

MESO PE Ratio:

MESO PEG Ratio: Not Available

MESO Forward EPS Growth (12 month): 0.00%

MESO PS Ratio: 28.6

MESO PSG Ratio: 0.9

MESO Forward Revenue Growth (12 month): 31.10%

MESO Articles

No data was found